Synthesis and stability test of radioimmunoconjugate 177Lu-DOTA-F(ab′)2-trastuzumab for theranostic agent of HER2 positive breast cancer-Reference-Cited by-同舟云学术

Synthesis and stability test of radioimmunoconjugate 177Lu-DOTA-F(ab′)2-trastuzumab for theranostic agent of HER2 positive breast cancer

Published:2016-10 Issue:4 Volume:9 Page:441-448
ISSN:1687-8507
Container-title:Journal of Radiation Research and Applied Sciences
language:en
Short-container-title:Journal of Radiation Research and Applied Sciences

Author:

Hermanto Sandra¹²,Haryuni Ratna Dini³,Ramli Martalena³,Mutalib Abdul⁴,Hudiyono Sumi¹

Affiliation:

1. Department of Chemistry, Faculty of Mathematics and Science, University of Indonesia, Depok, 16424, Indonesia

2. Study Program of Chemistry, Faculty of Science and Technology, Syarif Hidayatullah State Islamic University, Jl. Ir, H. Juanda No. 95, Ciputat, Jakarta, 15412, Indonesia

3. Centre for Radioisotopes and Radiopharmaceuticals, National Nuclear Energy Agency of Indonesia, Kawasan Puspiptek, Setu, Kota Tangerang Selatan, Banten, 15314, Indonesia

4. Department of Chemistry, Faculty of Mathematics and Science, Padjadjaran University, Jl. Raya Bandung-Sumedang Km. 21, Jatinangor, Jawa Barat, Indonesia

Funder

Centre for Radioisotopes and Radiopharmaceuticals

National Nuclear Energy Agency of Indonesia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1016/j.jrras.2016.07.001

Reference20 articles.

1. R.FirestoneV.S.ShirleyTable of isotopes8th ed.1996WileyNew York

2. Novel Engineered Trastuzumab Conformational Epitopes Demonstrate In Vitro and In Vivo Antitumor Properties against HER-2/neu

3. Preparation of F (ab’) 2 trastuzumab fragment for Radioimmunoconjugate synthesis of 177Lu-DOTA-F (ab’)2- trastuzumab

4. Optimizing radioimmunoconjugate delivery in the treatment of solid tumor

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of HER2 protein expression and clinical prognosis based on CT texture analysis in the arterial phase of gastric cancer;Journal of Radiation Research and Applied Sciences;2023-06

2. Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer;Advanced Pharmaceutical Bulletin;2023-04-29

3. Analysis of absorbed dose in radioimmunotherapy with 177Lu-trastuzumab using two different imaging scenarios: a pilot study;Nuclear Medicine Communications;2021-08-17

4. AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions;Nuclear Medicine and Biology;2021-05

5. Theranostic Approach in Breast Cancer;Clinical Nuclear Medicine;2021-04-30